• Abraham Sunday Alabi, Afsatou Ndama Traoré, Marguerite Massinga Loembe, Ulysse Ateba-Ngoa, Matthias Frank, Ayola Akim Adegnika, Bertrand Lell, Jocelyn Mahoumbou, Carsten Köhler, Peter Gottfried Kremsner, Martin Peter Grobusch, and CERMEL TB CapDev Group.
• Centre des Recherches Médicales de Lambaréné (CERMEL), PB 118, Lambaréné, Gabon; Eberhard Karls Universität, Institut für Tropenmedizin, Tübingen, Germany. Electronic address: aalabi02@yahoo.co.uk.
• Int. J. Infect. Dis. 2017 Mar 1; 56: 81-84.

AbstractBoth routine and research tuberculosis (TB) laboratory capacity urgently need to be expanded in large parts of Sub-Saharan Africa. In 2009, the Centre de Recherches Médicales de Lambaréné (CERMEL) took a strategic decision to expand its activities by building TB laboratory capacity to address research questions and to improve routine diagnostic and treatment capacity. Over the past 7 years, a standard laboratory has been developed that is contributing significantly to TB diagnosis, treatment, and control in Gabon; training has also been provided for TB research staff in Central Africa. CERMEL has a cordial relationship with the Gabon National TB Control Programme (PNLT), which has culminated in a successful Global Fund joint application. This endeavour is considered a model for similar developments needed in areas of high TB prevalence and where TB control remains poor to date.Copyright © 2016 The Author(s). Published by Elsevier Ltd.. All rights reserved.

21 keywords...

hide…